174900.KQ

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
174900.KQAbClon Inc.	$20250.00	-2.17%	$403.5B	—
050890.KQSOLiD, Inc.	$9110.00	+4.11%	$545.9B	—
090710.KQHyulim ROBOT Co.,Ltd.	$6090.00	-0.81%	$727.8B	—
094170.KQDongwoon Anatech Co., Ltd.	$26750.00	-1.11%	$540.7B	—
099430.KQBio Plus Co., Ltd	$3260.00	+1.72%	$200.6B	—
102940.KQKolon Life Science Inc.	$14050.00	+0.07%	$183.9B	—
144510.KQGc Cell Corp.	$14170.00	+1.07%	$212.9B	—

Source: Financial Modeling Prep · peers by sector/industry

AbClon Inc.

Founded in Seoul, South Korea, in 2010, AbClon Inc. is a biopharmaceutical company engaged in the discovery and development of antibody-based drugs, with operations spanning South Korea and Sweden. The firm's developmental pipeline encompasses therapies derived from distinct technological platforms: the NEST platform addresses breast and gastric cancers; the AffiMab platform targets colon cancer and various autoimmune conditions; and the CAR-T platform is engineered for hematologic and ovarian cancers.

www.abclon.com

Employees: 66
IPO / List date: Sep 18, 2017
HQ: KR

Held by traders on TradeandTell

No one on the platform currently holds 174900.KQ.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in 174900.KQ as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded 174900.KQ yet.